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Abstract: This paper presents a new remote healthcare model, which, exploiting wireless biomedical
sensors, an embedded local unit (gateway) for sensor data acquisition-processing-communication,
and a remote e-Health service center, can be scaled in different telemedicine scenarios. The aim is
avoiding hospitalization cost and long waiting lists for patients affected by chronic illness who need
continuous and long-term monitoring of some vital parameters. In the “1:1” scenario, the patient has
a set of biomedical sensors and a gateway to exchange data and healthcare protocols with the remote
service center. In the “1:N” scenario the use of gateway and sensors is managed by a professional
caregiver, e.g., assigned by the Public Health System to a number N of different patients. In the “point
of care” scenario the patient, instead of being hospitalized, can take the needed measurements at
a specific health corner, which is then connected to the remote e-Health center. A mix of commercially
available sensors and new custom-designed ones is presented. The new custom-designed sensors
range from a single-lead electrocardiograph for easy measurements taken by the patients at their
home, to a multi-channel biomedical integrated circuit for acquisition of multi-channel bio signals,
to a new motion sensor for patient posture estimation and fall detection. Experimental trials in
real-world telemedicine applications assess the proposed system in terms of easy usability from
patients, specialist and family doctors, and caregivers, in terms of scalability in different scenarios,
and in terms of suitability for implementation of needed care plans.
Keywords: wireless biomedical sensors; healthcare embedded platform; chronic health patient
monitoring; biomedical data gateway; e-Health service center
1. Introduction
One of the main trends in biomedical applications is developing telemedicine systems for the
remote monitoring of people affected by chronic diseases [1–16]. Particularly in developed countries
such as the United States, Canada, Europe, Japan, South Korea, and Australia, the increasing percentage
of elderly people and the need for public health systems (PHS) to cut the budget for hospitalization are
fostering the rise of a new healthcare paradigm: hospitalization should be reserved only for patients
with acute syndromes that can be solved in a short period. The healthcare model for patients affected
by chronic illness, and needing continuous and long-term monitoring of some vital parameters should
be based on telemedicine. According to a medical protocol established by a doctor, some biomedical
parameters of the patient are periodically measured at home or in a point of care (e.g., a pharmacy)
by the patients themselves, their relatives, or a professional caregiver (e.g., a nurse paid by the PHS
or by medical insurance). The biomedical signals to be measured depend on the specific illness and
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may include measurements of ECG (ElectroCardioGraphy), blood pressure, body temperature and
weight, oxygen saturation level in the blood (SpO2), chest impedance, hearth rate and breath rate,
and glycemia. These are the main parameters relevant for the three main chronic illnesses in western
countries: Chronic Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), and diabetes.
These types of chronic illness affect approximately 15 million people in Europe, with an incidence
of 3.6 million new cases every year; and the trend is the same in the United States [4]. Moreover,
in this work we add proper motion sensors to measure the posture of the patient, which influences
the measure of some biomedical parameters. Indeed, false alarms can be generated if the vital signs
are acquired in a non-correct position of the patient. As an additional service, motion sensors are also
useful for fall detection and consequent alarm generation. Fall detection is one of the main causes of
home accidents for elderly people. Telemedicine is also a key technology for overcoming the problem
of remote regions with low population density, where hospitals can be far from the town where people
live (e.g., internal and/or mountain zones of Europe or the United States).
It is worth noting that the technologies discussed in this paper can enable telemedicine to reduce
the hospitalization of patients, but cannot decide which patients will be hospitalized and when.
The decision about how many patients (and which ones) are acute and should be hospitalized, and how
many patients (and which ones), although affected by a chronic illness, are non-acute and should be
monitored remotely will depend on the medical protocol defined by specialist doctors, and on the
budget constraints of the PHS. If during the remote monitoring the patient’s biomedical parameters get
worse, according to the medical protocol established by the doctors, the patient can be re-hospitalized.
In the rest of the paper, Section 2 presents the state of the art and highlights the main contributions of
this work. Section 3 presents the remote healthcare model and the embedded processing/communication
platform. Section 4 is focused on the communication between the gateway at the client side and
the e-Health service center at the server side. Section 5 deals with biomedical sensors using COTS
(Commercial off the Shelf) components and three new custom-designed biomedical devices. The new
custom-designed sensors include a single-lead ECG for easy CHF measurements taken by the patients
at their home; a multi-channel biomedical ASIC (Application Specific Integrated Circuit) for acquisition
of multi-channel ECG, EEG (ElectroEncephaloGraphy) or EMG (ElectroMioGraphy), blood pressure,
and body temperature; and a new motion sensor for patient posture estimation and fall detection.
Experimental trials are addressed in Section 6. Conclusions are drawn in Section 7.
2. Review of the State of the Art and Main Contributions of the Work
Several state-of-the-art wearable sensors and telemedicine platforms [3,4,17–39] have been
proposed in the literature, but a successful and universal healthcare model is still missing. The main
reason is that most works are only focused on a specific sub-part of the system, or on a specific type
of disease. For example, [17,19–23,27–29] are focused on integrated smart sensors. Many studies
(e.g., [18,25,30,31]) are focused only on the acquisition and communication gateway or on the remote
server connected to the hospital information system (HIS). Moreover, [3,4,17,25,33–39] and [26,27] deal
only with the monitoring of patients affected by heart disease and diabetes, respectively. Studies [19–23]
are focused only on posture estimation and fall detection in patients. In [28–30] only contactless
detection measurement of breath rate and/or heart rate is presented. Furthermore, most of these
works come from academia and fail to address the qualification and certification issues of real-world
biomedical applications. Most of the above works present just a new sensor, without any integration of
real-world telemedicine scenarios that are characterized by multiple actors: patients and their relatives,
professional caregivers (family doctor, nurse, specialist doctor), call centers, which are operating at
home, or the hospital or points of care such as a pharmacy or a residence for elderly people.
Most current biomedical monitoring platforms try to exploit the computational and communication
capabilities of smartphones with touchscreen user interface, or even with smartwatches [21,24,26,30–32].
This way, state-of-the-art works are missing one of the key features of a telemedicine service: easy
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usability of the interface for users, who are mainly elderly people. Smartphones and smartwatches are
more suited for wellness applications targeting younger people.
To address these issues, this paper presents a new remote healthcare model, exploiting wireless
biomedical sensors that can be scaled to different telemedicine scenarios:
- The “1:1” scenario, where each of the patient has a set of biomedical sensors and an embedded
acquisition, processing, and communication platform (hereafter called a gateway) to exchange
data and healthcare protocols with a remote service center and/or HIS for telemedicine,
where a doctor is connected.
- The “1:N” scenario where the embedded acquisition and communication telemedicine platform
is manged by a nurse, e.g., assigned by the PHS to a number N of different patients. The nurse is
visiting and taking care of data acquisition from a set of N patients. The relevant biomedical data
are then transmitted to the remote service center and/or HIS. In the “1:N” scenario it is the nurse
that is moving and visiting patients at their homes.
- The “point of care” scenario where a local building, e.g., a pharmacy, or a point of care in
a school or a residence for elderly people, hosts the embedded acquisition and communication
telemedicine platform and the set of sensors. The patients, instead of being hospitalized,
with increased cost and waiting lists, can take the needed measurements at a specific point of care,
which is then connected to the remote service center and/or HIS. In this scenario the patients
are moving toward the point of care where a nurse supervises the biomedical measurement
acquisitions to be collected and transmitted.
In this paper, different from the state of the art, the whole value chain is implemented from the
health care model at the top, down to the technical implementations of sensors, data acquisition and
communication platform, and integration with the service center and HIS. The work is the result of
the collaboration between academia (the University of Pisa) and industry (IngeniArs S.r.l.), the latter
being responsible for integration in different real-world telemedicine scenarios, taking care of all actors
involved, including certification and qualification issues.
The communication between the home gateway and the HIS is based on approved medical
protocols such as HL7 CDA (Clinical Document Architecture). The communication is physically
running on wireless technologies available everywhere, like 3G or 4G cellular network, or satellite
connections, wired technologies like ADSL/VDSL (Asymmetric or Very-high speed Digital Subscriber
Line), or Fiber to the Cabinet/Home (FTTC/FTTH).
The platform can be used to implement a predefined measuring protocol, i.e., a care plan assigned
remotely by the family or specialist doctor. Extra-protocol measurements can be taken by the patient
or the caregiver in case of necessity or can be requested remotely by the doctor. A mixture of COTS
sensors and custom ones specifically designed by the research group are presented and used in this
work. With respect to previous publications of the authors in [4,17,25,28], this work is extended
in terms of:
- Support of any chronic illness and not only CHF as in [4,17,25].
- Analysis of the system-level telemedicine model with differentiation of the biomedical monitoring kit
according to the above scenarios: “1:1”, “1:N,” and “point of care,” which is missing in [4,17,25,28].
- Development of new custom sensors, particularly the single-lead ECG one for easy self-measurements
at home, whereas [4,25,28] were mainly based on commercial sensors.
- Integration of motion sensors for fall detection and patient’s posture analysis, missing in [4,17,25,28].
This work also presents real-world results from experimental trials carried out in the field of
several European and regional research and health projects such as Health@Home (EU Ambient
Assisted Living program), RIS and RACE (EU-Tuscany Region FESR program), and Domino (Tuscany
region PHS project).
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3. Remote Healthcare Model and Embedded Sensing/Communication Platform
According to Figure 1, the proposed telemedicine model includes several elements to cover the
different sub-systems belonging to a distributed health care system. The key blocks in Figure 1 are:
- A monitoring kit (embedded sensing and communication platform, oval A with green borders
in Figure 1, whose description is detailed in Sections 3.1–3.3) which, depending if the “1:1” or
“1:N” scenario is implemented, can be used by patients for self-measurement or by caregivers,
e.g., nurses, during planned home visits.
- A totem for the monitoring of the biomedical parameters to be installed at point of cares
(e.g., pharmacies, residences for elderly people, or other healthcare points); this is the embedded
sensing and communication platform indicated with oval B with green borders in Figure 1,
whose description is detailed in Sections 3.1 and 3.4).
- Management platform of the electronic health record and of the home-care plan (e-Health
center detailed in Section 4), integrated with the HIS, and available to specialist doctors directly
or through operators of a service center. Optionally, through the service center the data of
the electronic health record can also be made available to the family doctor. Alarms can be
automatically generated by the embedded sensing/communication units (thanks to local signal
processing capability) at home or at the point of care, or by a caregiver analyzing the data.
Automatically generated alarms should be validated by a caregiver. An alarm, generated or
validated by a caregiver, is communicated to emergency units for a fast re-hospitalization of the
patient and, optionally, to a pre-selected list of relatives/friends.
Electronics 2016, 5, 47 4 of 26 
 
3. Remote Healthcare Model and Embedd d Sensing/Communication Platform 
According to Figure 1, the proposed telemedicine model includes several elements to cover the 
different sub-systems belonging to a distributed health care system. The key blocks in Figure 1 are: 
- A monitoring kit (embedded sensing and communication platform, oval A with green borders 
in Figure 1, whose description is detailed in Sections 3.1–3.3) which, depending if the “1:1” or 
“1:N” scenario is implemented, can be used by patients for self-measurement or by caregivers, 
e.g., nurses, during planned h me visits. 
- A totem for the monitoring of the biom dical parameters to be installed at point of cares (e.g., 
pharmacies, residences for elderly people, or other healthcare points); this is the embedded 
sensing and communic tion platform indicated with oval B with green borders in Figure 1, 
whose description is detailed in Sections 3.1 and 3.4). 
- Management platform of the el ctronic health record  of the home-care plan (e-Health center 
de ailed in Section 4), integrated with the HIS, and available to specialist doctors direc ly or 
t rough perators of a service center. Option lly, through the service center the data of the 
electron  health ecord can also be made available to the family doctor. Alarms can be 
automatically generated by th  embedd d se sing/communication un ts (thanks to local sign l 
processing capability) at home or at the point of care, or by a caregiver analyzing the ata. 
Automatically generated alarms should be validated by a caregiver. An alarm, generated or 
validated by a caregiver, is communicated t  emergency units for a fast re-hospitalization of the 
patient and, optionally, to a pre-selected list of relatives/friends. 
 
Figure 1. Distributed health care system for chronic illness monitoring. 
3.1. Biomedical Sensing and Communication Platform 
The reference architecture of the biomedical monitoring kit is reported in Figure 2. It includes: a 
set of wireless sensors, connected through a Bluetooth wireless technology to an embedded system 
(called gateway) in charge of biomedical sensor signal acquisition, local processing, and data storage, 
and three interfaces: one for the user, one for the sensors, and the other for the e-Health center. 
Figure 1. Distributed health care system for chronic illnes monitoring.
Electronics 2016, 5, 47 5 of 27
3.1. Biomedical Sensing and Communication Platform
The reference architecture of the biomedical monitoring kit is reported in Figure 2. It includes:
a set of wireless sensors, connected through a Bluetooth wireless technology to an embedded system
(called gateway) in charge of biomedical sensor signal acquisition, local processing, and data storage,
and three interfaces: one for the user, one for the sensors, and the other for the e-Health center.
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The latter exploits the SOAP web service paradigm on standard wired or wireless communication
technologies (e.g., WiFi, Mobile Broadband, Ethernet, etc.). To increase the system flexibility, besides
the HL7 CDA standard data format, the proposed system also supports other protocols for client–server
communication like JSON (JavaScript Object Notation) and XML (eXtensible Markup Language).
For the sensors inte face, Bluetooth (BT) technology has been preferred to other 802.11x WLAN
(Wireless Local Area Network) or 802.15x WPAN (Wireless Personal Area Network) technologies
for its large diffusion, increasing the number of commercial sensors that can be selected and used.
The gateway handles the communication via the dual-mode BT interface: the RFCOMM protocol (Serial
Port Profile SPP) is sed to handle legacy Bluetooth 2.0 s ns rs, whereas the profiles HDP (Health
Device Profile) [32] or GATT (Generic Attribute Profile) are used to communicate with Bluetooth
Low-Energy (BLE) devices. Relying on a dual-mode BT chipset, the gateway is able to handle both
legacy BT and BLE devices, acquiring data from a single sensor per time. The number of connectable
sensors is unlimited and the gateway is able to manage both master and slave sensors. Pin-based
pairing procedure and eventual data encryption are available. The performance of BT, even in
a low-power protocol version, is well suited for telemedicine applications. Indeed, the main features
of BLE are: data rate up to 1 Mb/s; connection distance up to 100 m outdoor line-of-sight but at least
meters indoor; supported security technology (128 bit Advanced Encryption Standard) and robustness
techniques (Adaptive frequency hopping, Lazy Acknowledgement, 24-bit Cyclic Redundant Code,
32-bit Message Integrity Check), low communication latency of few ms, and low power consumption
limited to a few tens of mW, since a current well below 15 mA is drained from a power supply of
few Volts.
It is worth noting that the gateway can also implement local signal processing tasks and not only
acquisition, communication, and user interface tasks. Supported signal processing functionalities are:
- Collection of the acquired data from the configured BT or BLE sensors to create statistics of the
biomedical parameters acquired according to the specific plan.
- Graphical rendering for the visualization of the historical evolution of the biomedical parameters
acquired according to the specific plan (see an example in Figure 3 related to the evolution of the
SpO2 parameter). The statistics and graphical rendering of the historical evolution of biomedical
parameters are useful at the gateway side mainly in the “1:N” and in the “point-of-care” scenarios
(where the remote acquisition of bio-signals is supervised by a professional caregiver). They are
also made available at the remote server side (service center and HIS).
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- Threshold-based analysis of the acquired data so that an early warning can be sent when one of
the acquired parameters is above or below a specific threshold that can be changed dynamically
and remotely by the doctor. The early warning can be used to force an immediate hospitalization
in case the chronic illness enters into an acute phase.
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From a hardware point of view, the gateway can be implemented on a general purpose system
such as smartphones, tablets, or custom boards. The minimal requirements for the implementation are:
32 bit ARM Cortex processor, 1 GB RAM memory, at least 4 GB Flash Non-volatile storage, dual-mode
Bluetooth chip t, network connectivity (e.g., Wifi, Ethernet, mobile broadband), and Androi OS.
On top of the hardware, a custom s ftware layer has been devel ped using Java and the Android
Software Development Kit (SDK). The strategic decision to use Java technology provides extreme
flexibility concerning the configurability. Java also guarantees easy portability. The system is easily
scalable in different processors and Printed Circuit Boards (PCBs). For example, one implemented
configuration resulted in a compact size of 15 cm ˆ 7 cm ˆ 7 cm. Instead, in a configuration requiring
a screen of 10 inches, the hardware is organized so that a size of about 22 cm ˆ 14 cm ˆ 1 cm is
obtained. Solutions based on commercial tablets and smartphones have also been developed.
3.2. “1:1” Scenario
Changing the scenario (“1:1” or “1:N” or “point of care”) means changing who is supervising the
biomedical measurement activity: the patient or his/her relatives (non-professional users), or a nurse
(professional user). With reference to the architecture of the monitoring kit in Figure 2 (which includes
a set of wireless sensors connected through a BT or BLE technology to the embedded platform for data
acquisition and communication), which is valid for all scenarios, the user interface and also the type of
sensors to be used have to be specifically adapted to the different scenarios and the different users.
For example, a conventional 12-lead ECG biomedical instrumentation, providing complete and
accurate measurements of heart activity, is not suited to the “1:1” scenario where a non-professional
caregiver (the patient or his/her relatives) is supervising the measurement acquisition. If used by
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a non-professional caregiver, an ECG with lots of derivations will often have the electrodes placed in
the wrong position or with a bad electrode–body contact, thus giving inaccurate results. This is why,
in the following, for the different scenarios, different sets of building blocks must be used. Moreover, for
some specific blocks, e.g., ECG, a new custom instrumentation has been designed (e.g., the single-lead
ECG in Section 5.2).
In the “1:1” healthcare model, already described in Section 2, the gateway allows the user to view
the individual care plan established by the family or specialist doctor, collect the measurements from
medical sensors, through a BT or BLE connection, and send them to the e-Health Center (a service center
and/or the HIS) through a wired or wireless Internet connection (see Figures 4 and 5). The patient
also has the possibility to carry out a measurement not foreseen in the standard care plan. At a time
when the activity is required, visual and audible signals inform the patient that a new measurement is
required (see Figure 5). An animated image guides the patient on how to use the device to complete the
task. The numbers near the arrows in Figures 5–7 highlight the temporal consecution of the different
steps. After the measurement, the gateway notifies the patient if the activity was successful or s/he will
need to repeat the operation. The user interface has been optimized for elderly people with a simplified
graphic, using a touch-screen display of at least 10 inches with large buttons. The language can be
customized for the specific nation where the system is used.
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3.3. “1:N” Scenario
In the “1:N” scenario, instead, the professional monitoring kit allows the nurse to take measurements
of vital signs during home visits to different patients. As reported in Figure 6, first the gateway allows
the nurse to select the specific patient (based on his/her health card or fiscal code, for example) and
view the individual care plan for each patient. The user interface then guides the operator in the
execution of the measures indicated in the plan. The system also allows the collection of unplanned
measures and allows the repetition of the measurements made. Since the user is a professional one,
more complex visualizations such as the ECG trace are available. The gateway can also work in offline
mode, by sending all the measurements acquired at the end of the home visits. The professional
operator selects the patient from the list of the clients and takes the measures foreseen in the individual
care plan, making sure that the quality of the measurement is satisfactory. If it is not, s/he can proceed
with a repetition of the measurement. The acquired measurements are sent to the e-Health Center,
through the Internet connection. Figure 6 reports the complete flow.
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3.4. “Point of Care” Scenario
In the “point of care” scenario, also called Totem mode (see Figure 7), the telemonitoring totem
allows the measurement of the principal vital signs at dedicated facilities (pharmacies, residence
for elderly people, etc.) and their transmission in the patient’s electronic file through the Internet
connection. The professional caregiver identifies the patient through his/her fiscal code or by scanning
his/her health card and takes the measures provided for the individual care plan, making sure that
the quality of the measurement is satisfactory. If it is not, s/he can proceed with a repetition of the
measurement. The acquired measurements are sent to the e-Health Center, through the Internet
connection. This scenario is similar to the “1:N” scenario, but here the patients are moving toward the
health center. Moreover, the patient database is larger since a larger number of patients are followed.
In all of the above cases the access by the user is done in secure mode through a login–password protocol.
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4. Home Monitoring Unit vs. e-Health Center Client–Server Communication
In the proposed health model the remote e-Health center in Figure 8 plays an essential role,
since it integrates the services performed on the territory within the medical environment and the
HIS. As reported in Figures 1 and 8, it includes a service center and the interface toward the HIS.
The e-Health center is the central element of the overall modular system, in which specialized human
operators and ICT resources allow for managing data flows and events.
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Concerning the presented telemedicine platform, the e-Health center is in charge of three
important tasks. The first one is to manage the bidirectional communication with the gateway of the
home monitoring module to receive data and send configurations. The second task is to provide the
data processing capabilities and interfaces for the local service center operators and the other remote
human operat rs of the system, respectively ( .e., users of the other modules). The last task is the
synchronization of t e clinical data with the ele tronic h alth record. Figure 8 shows the block diagram
of the remote e-Health center including an intermediate node, the service center, and the connection
with the HIS where the electronic health record of the patient is stored and where the specialist doctor
can access and manage the telemedicine data and care plan.
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Communications between the gateways, which are distributed throughout the area, and the
acquisition block of the remote e-Health center take place through the public network. The acquisition
driver implements the receiving endpoint, which is a SOAP (Simple Object Access Protocol) web
service based on the HTTPS (Hyper Text Transfer Protocol, known as HTTP, over Secure Socket Layer,
known as SSL) protocol able to manage both XML and HL7 CDA standard contents. Data coming
from gateways are the results of the measurements performed by the caregivers. These are stored in
the integrated database in order to be available for the other actors of the distributed telemedicine
system. The remote e-Health center also manages the personalized monitoring protocol for each
patient enrolled in the telemedicine program in terms of measurements to take and thresholds for
alarm generation. The protocols of several patients can be loaded and updated remotely by calling
from the gateway a dedicated configuration endpoint.
Dedicated software processes the received data by means of specific algorithms in order to find
critical situations or dangerous alterations of vital signs. For example, those for CHF have already
been published by the authors in [4]. It is possible to define personalized analysis profiles based
on the needs of a specific patient. The processed information is stored into the integrated database
and made available to the operators through different levels of the interface. The local interface is
available only to service center operators and enables them to manage all the phases of telemedicine
service provision. It allows for the enrollment and classification of new patients, the definition and
updating of the treatment protocol for each patient, the establishment of personalized vital signs
analysis profiles, and visualization and interaction with current and past measurements of vital
signs. Moreover, it permits the operator to manage alarms or critical situations, eventually involving
territorial emergency services or other appointed modules of the integrated system. Indeed, the remote
interface allows professional operators (e.g., family doctors in Figure 1, etc.) to remotely access a subset
of clinical information contained in the integrated database.
Another important role of the e-Health center is that of the relay agent for the clinical information
received from the gateways with respect to the final destination, i.e., the electronic health record
(see Figure 8). This process is completely transparent to the medical personnel and allows the
information collected by the caregiver on the territory to be available in a few minutes in all offices
that have access to the HIS. In this way, the electronic health record of each patient represents
a deep anamnestic database and helps the medical personnel to improve the quality of treatment by
developing therapy tailored to the specific patient’s needs.
In such a system, in which critical and personal information are exchanged through the public
Internet, the confidentiality, data integrity, and authenticity of the communicating parts are among
the major requirements. In the presented platform we selected the HTTPS protocol to protect all the
communications between the gateways and the e-Health center. This protocol provides the normal
HTTP request–response mechanism typical of web-based or web service-oriented applications over
an SSL or TSL (Transport Layer Security) encrypted end-to-end tunnel. The communicating parties
firstly authenticate themselves using the X.509 certificate, then use their asymmetric keys to establish
and exchange a symmetric session key that will be used to encrypt all the traffic. Message hashing
ensures the data integrity over the session tunnel.
Concerning hardware and software implementation, the service center consists of a room where
specialized operators (i.e., trained operators, nurses, or specialist doctors) interact with the ICT
infrastructure through dedicated terminals of a Linux-based server machine that hosts the integrated
database (Oracle), runs the communication drivers and the processing software for alarm generation,
and finally provides the graphical user interfaces. All the equipment running on the service center
server received the CE certification according to the 93/42/CEE directive following integrations for
data generation, interpretation, and visualization. In fact, this software has been classified as a class IIa
medical device. It is compliant with the standard ISO 62304—medical software life-cycle, the standard
ISO 14971—Risk management in medical devices, the standard ISO 60601—alarm systems in medical
devices, and ISO 62366—usability engineering in medical devices.
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In this telemedicine platform, vital signs data collected by CE certified biomedical devices are
provided and interpreted for diagnostic purposes only through CE certified software. In this way,
the acquisition and transmission chain involves certified elements and medical devices only at the
extremities, while the gateway and the other intermediate elements simply propagate the information
without dealing with the content. Patients use the wireless medical devices assigned to them,
and the data is sent automatically to the e-Health Center through a gateway. The data received
by the gateway are managed in raw format and wrapped in XML before transmission. The e-Health
Center parses the raw data received through a CE-marked data interpretation driver in order to allow
their use for medical purposes (diagnosis, therapy, etc.). In this way, even in case the intermediate
gateway is not CE-marked as medical devices, the whole chain maintains the certification, because
critical data are only generated by and managed by CE-certified elements.
The e-Health Center is a multi-disease, multi-device, multi-parameter, multi-language, multi-tenant
web platform for the management of patients and the remote monitoring of their vital parameters.
An alarm is signaled every time a parameter is not received within the patient’s schedule, and also
if a parameter falls outside the ranges. Each patient has different ranges for red, yellow, and cyan
alarms on each parameter. Specialized operators receive the alarms and handle them with appropriate
protocols, which typically include contacting in a defined order one or more of: the patient, his/her
caregivers, agreed neighbors and relatives, the family doctor, emergency services as ambulance, the fire
brigade, etc. Depending on the established medical protocol, in the proposed system, the specialized
operator in charge of alarm management can be the specialist doctor taking care of that specific patient,
or a generic caregiver (i.e., trained operators, doctors of the hospital, or also a nurse). The operator
performs further calls as needed and monitors the situation until resolved, recording in the e-Health
Center all his/her activities and their outcomes. Patients can also have emergency (“panic”) buttons to
directly call operators for remote assistance. The server application for the e-Health center is composed
of the following software components:
- Relational database: stores all the data and contains most application logic—including
object-oriented PL/SQL data models, patient schedules, and alarm triggers. It is in charge
of enforcing users’ permissions.
- Java Enterprise Edition (JEE) web application, which implements and publishes the AJAX-based
web 2.0 interface.
- Driver: receives the raw data sent by gateways, parses them, and inserts the parsed measurements
into the database.
- Audit and Security System: monitoring component that detects and reports any malfunctioning.
It also records the system activity.
The other main element of the architecture is the server gateway integration engine. This element
is the link between data and the large set of heterogeneous management platforms on which the
telemedicine services are based on. The technology used for the development of this part of the system
is the JEE. From the functional point of view this module:
- Receives raw data embedded into XML tags from the client gateway.
- Transmits to the client gateway the agenda of the configured patient.
- Allows the complete management of patients.
- Transmits data to the server of the service centers with specific adapters.
- Receives agenda by external clinical data management tools.
5. Wireless Biomedical Sensors
5.1. Wireless Sensor Selection
As discussed in previous sections, the proposed system exploits wireless biomedical sensors
with BT and BLE connectivity. The telemedicine market is still growing, so standards are not
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frozen. Moreover, qualification and CE certification for medical use of a new device entail significant
development time and costs. Development of a new sensor makes also sense for devices with high
added value, with a key difference vs. the state of the art, or with a high potential market. For this
reason, the approach we followed is developing custom sensors in three cases:
- A single-lead ECG sensing device, patent-filed technology [33], which allows for self-monitoring
of the heart in an easy way without the need to connect lots of electrodes in different parts of the
body, but simply placing the two hands of the patient on top of a couple of electrodes. This sensor
is further discussed in Section 5.2. This sensor, although simple and easy to use, can provide
a graphical trace of the ECG and automatic measurement of heart rate and its statistics, thus being
useful for arrhythmia monitoring.
- An integrated multi-channel Biomedical ASIC with a configurable sensor front-end [40,41],
which allows multiple electrodes for multi-channel ECG or EEG or EMG measurements plus
body temperature and blood pressure monitoring. The ASIC also supports automatic detection of
pacemaker signals to avoid false alarm generation. This sensor is further discussed in Section 5.3.
- A motion sensor for correct detection of the patient’s posture and possible falls. Indeed,
the measurement of most biomedical parameters is influenced by posture. Therefore, the posture
of the patient has to be acquired during remote monitoring to reduce the rate of false alarms or
missed detection. As an additional service, motion sensors allow for the detection of patient falls
and consequent alarm generation. Falls in elderly people are one of the main causes of accidents
at home. This sensor is further discussed in Section 5.4.
The other sensors we selected are already qualified (i.e., CE certified) commercial wireless medical
devices. Here the focus of our work has been first, together with medical staff from Fondazione
Toscana Gabriele Monasterio, to define the set of measurements to take for each of supported chronic
illness (CHF, diabetes, COPD) and the relevant requirements. Sensor specifications have been set
in terms of dynamic range, acceptable noise and interference levels, signal bandwidth, sensitivity,
and usability. Starting from this analysis, a set of BT and BLE sensors has been selected and integrated
within the acquisition platform discussed in previous sections. Table 1 shows the main characteristics
of the commercial sensors that have been used for the different illnesses monitored by the proposed
biomedical platforms. Power consumption of commercial devices, as reported in their respective
user manuals, is suitable for two or three months of use in a telemedicine service that requires one or
two measurements per day. For example, the Cardioline Microtel Cardiette ECG device ensures at
least 7 h of use with the same battery. This means that, assuming 2 min per measurement, the batteries
need to be replaced about every 100 days.
Table 1. List of COTS biomedical sensors.
Sensor Chronic Illness Device Characteristics
Cardioline Microtel
Cardiette CHF
3/6/12 channels derivation; ECG continuous
measurement; 0.05–150 Hz; sampling rate 500 Hz;
pacemaker detection; BT 2.0 SPP
A&D weighting scale
(UC-321PBT) CHF Range 0–200 kg, resolution 100 g; BT 2.0 SPP
A&D blood pressure
(UA-767PBT) CHF, COPD
Range: pressure 20–280 mmHg, pulse: 40–200 bpm;
Accuracy: pressure ˘ 3 mmHg, pulse: ˘5%; BT 2.0 SPP
Nonin saturimeter
(Onyx II 9560) CHF, COPD
Range: SpO2 0%–100%, pulse 20–250 bpm; Accuracy:
SpO2 ˘ 1, pulse ˘ 3 bpm
Lifescan Glucometer
(onetouch ultraeasy) diabetes Range: 20–600 md/dL; Accuracy: ˘5%; BT 2.0 SPP
MIR spirometer (Spirodoc) COPD Range: flux ˘ 16 L/s, Accuracy: flux ˘ 5%; BT 2.0 SPP
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5.2. Single-Lead ECG Sensor
5.2.1. State of the Art Review and Specifications of Devices for Patient ECG Self-Measurements
Many modern ECG devices for telemonitoring use a wide variety of technologies and methods to
record the electrocardiogram from the patient and send it to the service center. For example, systems
like Intelsens V-Patch [34], Iansys Lifecare [35], or Lifewatch Lifestar ACT [36] make use of adhesive
disposable electrodes attached to the chest in order to detect the ECG. Then, proprietary wireless
protocols and gateways are used for the transmission of the ECG through an Internet connection.
A different method of ECG acquisition is adopted by DOCOBO doc@home [37], which uses four
dry metal electrodes in contact with the hands and transmits the recorded ECG through a wired
telephone connection. Other devices like Card Guard PMP4 SelfCheck ECG [38] or SolutionMD ECG
Mobile [39] use Bluetooth technology for sending data to a third party gateway. The device in [38]
acquires the signal through two dry metal electrodes put directly on the chest or, as an alternative,
using 10 wet adhesive electrodes connected to the device by a cable. The device in [39] instead uses
a number of capacitive wearable electrodes embedded in clothing. In many of these solutions the
ECG measurement device has a complex human–machine interface (HMI), presenting many different
functions and showing much information.
The main objective of the proposed ECG device is to be ergonomic and easy to use in order to
encourage patients to periodically record and send their own electrocardiograms following an assigned
plan. To achieve this goal patients, mostly elderly, should be able to use and maintain the device
in complete autonomy. Thus, it is important to ensure that a low number of simple operations are
required to record and send the ECG. Moreover, the interaction with the device should be easy and
immediate. The need to provide supplies of disposable specific materials, such as the electrodes,
could represent a problem especially for elderly people, who often have poor mobility. To develop
an ECG device satisfying the requirements described above, the main issue is represented by the
electrical contacts with the patient. The most practiced solutions involve the use of adhesive electrodes
placed on the chest, arms, and legs, connected to the ECG device with cables. A less frequent alternative
is the use of dry or wet metal electrodes, located on the device, to be put directly in contact with the
chest. Although these devices are able to acquire a number of ECG leads ranging from three to 12,
these solutions are not optimal for our purpose. An affordable solution may be to reduce the number
of leads to one and to find an easy way to establish and maintain the contact of the electrodes with the
body. For example, the patient could record the first lead of his/her own ECG signal just by placing
his/her hands on the device. Then the recorded ECG is sent to the gateway discussed in Section 3,
through an automatic preconfigured Bluetooth connection. Once the ECG device is paired with the
gateway, the user only has to make sure that both are switched on and wait for the ready-to-record
signal. Another important aspect is the HMI, which should be as simple as possible in order to allow
the device to be user-friendly. Since elderly patients usually do not have confidence with technology,
an interface that presents more than one or two buttons and many functions and indicators may be
a cause of rejection. The proposed solution involves a HMI with only one button for switching the
device on/off, a few LED indicators (green for power and red for heart rate), and a simple display
LCD (128 ˆ 64 pixels).
5.2.2. Analysis of the Skin–Electrode Contact and the Shape of a Hand-Based Single-Lead ECG Device
To acquire a good-quality ECG in a comfortable, quick, and easy way for the patient, it is
important to find the best configuration for contact with the hands and an ergonomic shape for the
device. Thus, one of the first steps was a study about the position of the hands on the contacts that was
carried out with the help of Lifepak 15, a commercial professional electrocardiograph. The Lifepak 15 is
equipped with two metal paddles, used for defibrillation, with which it is also possible to detect an ECG
lead. By placing the hands on the paddles in different configurations, it was possible to compare
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the different qualities of the signal detected. In a previous work [17] we tested several different
configurations, of which the four most interesting configurations are reported here:
(1) paddles kept singularly in each hand with the palms in contact with the metal electrodes;
(2) paddles attached to each other on the insulated back and kept in contact with the skin through
the pressure of the hands;
(3) paddles placed on a plane with the electrodes on the top, in contact with the fingers of each hand;
(4) paddles placed on a plane with the electrodes on the top, in contact with the proximal part of the
palm of each hand.
Comparing the ECG obtained, the best quality signal is achieved in the case where the palms of
the hands are placed on the electrodes. In the other cases, where the fingers are involved or where
muscle tension is needed to keep contact, the ECG presents some artifacts due to the difficulty of
avoiding small movements that cause variations in the pressure of the skin over the electrodes.
Once we assessed the best hand–electrode contact configuration, another step was to investigate
the best shape for an ECG device that will be ergonomic and comfortable to use. Several different shapes
and ways to handle them were proposed to tens of elderly people. From the feedback of the testers,
the configuration that best allows one to keep stable contact with the electrodes is a parallelepiped
having dimensions of about 30 ˆ 5 ˆ 3 cm3, with the electrodes placed on a plane with the long side
parallel to the chest, on which the user lays the proximal part of the palm of the hand. Testers also
reported that the greatest comfort is obtained when laying the hands on the shape instead of keeping
it steady with one’s hands. Furthermore, it is better to keep only the proximal part of the hand on the
electrodes to avoid pressure on the wrists. This will cause an annoying feeling of pulsation during
the measurement.
One of the most important aspects to be considered when using dry metal electrodes concerns the
contact impedances of the electrodes with the skin, which represents the source impedances of the
system [42]. Figure 9 shows a simplified model of the skin–electrode contact impedance that presents
resistive and capacitive components.
Electronics 2016, 5, 47 14 of 26 
 
(4) paddles placed on a plane with the electrodes on the top, in contact with the proximal part 
of the palm of each hand. 
o ari g t e  obtai e , t e best q ality sig al is ac ie e  i  t e case ere t e al s of 
t e a s are lace   t e electr es. I  t e t er cases, ere t e fi ers are i l e  r ere 
scle te si  is ee e  t  ee  c tact, t e  rese ts s e artifacts e t  t e iffic lt  f 
a i i  s all e e ts t at ca se ariati s i  t e ress re f t e s i  er t e electr es. 
ce e assesse  t e est a –electr e c tact c fi rati , a t er ste  as t  i esti ate 
t e est shape for an ECG device that will be ergonomic and comfortable to use. Several different 
shapes and ways to handle them were proposed to tens of elderly people. From the feedback of the 
testers, the configuration that best all ws one to keep stable contact with the electrodes is a 
parallelepiped having dimensions of about 30 × 5 × 3 cm3, with the electrodes placed on a pla e with 
the long side parallel to the c est, on which t e user lays the proximal part of t e palm of the hand. 
Testers also reported that the greatest comfort is obtained w en l ying the hands on the shape instead 
of keeping it steady with one’s ands. Furthermore, it is better to keep only the pr ximal part f t e 
hand on the electrodes to avoid pressure on the wrists. This will cause a  annoying feeling of 
pulsation during the measurement. 
e f t e ost important aspects to be considered when using dry metal electrodes concerns 
the contact impedances of th  electrodes with the skin, which represents the source impedances of 
the system [42]. Figure 9 shows a simplified model of th  skin–electrode contact impedanc  that 
presents resistive and capacitive components. 
 
Figure 9. Skin–electrode contact electric model. 
When a differential amplifier is used to capture the electrical cardiac signal between two 
electrodes, the values of the two source impedances have a significant influence on the quality of the 
output signal. If the source impedances are unbalanced, an amount of common mode signal 
transforms into a differential component at the input of the amplifier, worsening the Common Mode 
Rejection Ratio (CMRR) of the system. Since it is impossible to guarantee two identical contact 
impedances, especially if dry electrodes are used, it is important that the impedance values are as 
low as possible in order to minimize the absolute value of the difference. Moreover, the impedances 
are susceptible to variations in time due to changes in the pressure of contacts or in the local 
conductivity of the skin. This introduces low-frequency artifacts over the desired signal. Furthermore, 
the presence of a capacitive component of the electrode–skin interface could also introduce a phase 
distortion in the signal if the magnitude of the contact impedances is not negligible with respect to 
the value of the input differential impedance of the amplifier. Thus, it is important to study the 
properties of the contact impedances at the point of the body where the signal is detected. 
To understand the order of magnitude of the source impedances, a simple frequency 
characterization of the impedance of the hand–electrode contacts was made. A steel electrode, 
obtained from pediatric defibrillation paddles, was fixed to each hand using an elastic bandage to 
Figure 9. Skin–electrode contact electric model.
When a differential amplifier is used to capture the electrical cardiac signal between two electrodes,
the values of the two source i pedances have a significant influence on the quality of the output
signal. If the source impedances are unbalanced, an amount of common mode signal transforms
into a differential component at the input of the amplifier, worsening the Common Mode Rejection
Ratio (CMRR) of the system. Since it is impossible to guarantee two identical contact impedances,
especially if dry electrodes are used, it is important that the impedance values are as low as possible
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in order to minimize the absolute value of the difference. Moreover, the impedances are susceptible
to variations in time due to changes in the pressure of contacts or in the local conductivity of the
skin. This introduces low-frequency artifacts over the desired signal. Furthermore, the presence of
a capacitive component of the electrode–skin interface could also introduce a phase distortion in the
signal if the magnitude of the contact impedances is not negligible with respect to the value of the
input differential impedance of the amplifier. Thus, it is important to study the properties of the contact
impedances at the point of the body where the signal is detected.
To understand the order of magnitude of the source impedances, a simple frequency
characterization of the impedance of the hand–electrode contacts was made. A steel electrode, obtained
from pediatric defibrillation paddles, was fixed to each hand using an elastic bandage to keep a constant
pressure. A voltage-to-current converter and voltage amplifier circuit was realized to impose a current
between the two contact interfaces and to measure the voltage that occurs between the two electrodes.
By comparing the output signal with the input measured at different frequency values with the aid
of an oscilloscope, it was possible to obtain the sum of the two contact impedances. Assuming the
two impedances are equal, the value of one of them is half of the observed value. From experimental
measurements the maximum value of the impedance is about 10 kΩ at low frequencies (DC to 3 kHz),
while it decreases at higher frequencies. Since the magnitude of the skin–electrode impedance is
negligible with respect to the input impedance of a common instrumentation amplifier, the phase
value of the former was considered irrelevant.
5.2.3. Architecture of a Single-Lead ECG Device
Figure 10 represents the block diagram of the single-lead ECG biomedical device. It includes
two dry electrodes, an analog front-end, a microcontroller, a Bluetooth module, and a user interface.
The analog front-end circuit used to detect the ECG signal from the two contacts and to condition the
signal includes as input stage an instrumentation amplifier (IA). The IA stage converts the differential
input signal to a single-ended signal. The gain of this stage is low to avoid saturations due to input
offsets caused by the half-cell potential of the skin–electrode interfaces, usually ranging from 300 mV
to 1 V when unbalanced source impedances are present. The feedback loop on the reference pin of
the IA has been sized to implement a first-order high-pass filter that eliminates the output DC offset
acting on the reference voltage of the IA. The output of the IA is then amplified by a gain stage that
realizes a single pole low-pass filter and is finally supplied to the A/D converter of the microcontroller.
Filters are sized so that the overall band of the analog front-end is in the range of 0.5 Hz to 50 Hz.
The common mode unwanted signal at the input of the first stage is collected in the middle point of
the gain resistance of the IA. Then it is amplified by an inverting amplifier and inserted again into the
body through a third electrode in order to realize a negative feedback on the common mode disturbing
signal. This feedback loop is historically called “Right Leg Drive” and allows us to substantially
reduce the noise caused by the pairing of the patient with many sources of disturbing signals such as
power lines.
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An eight-bit RISC microcontroller evaluation board, the Atmel XMEGA-A3BU Xplained, was used
to realize the sampling, the digital elaboration, and the control of the system. The firmware performs
a fine-grained filtering of the ECG signal in the digital domain, provides the elaborated samples to
the Bluetooth 2.0 module with SPP profile, and manages the user interface. Moreover, an algorithm
calculates the heart rate. The sampling rate is 500 sps and the filter applied is a highly selective FIR
filter, built with 516 coefficients, having a passband ranging from 0.6 Hz to 37 Hz, and presenting
a notch response at 50 Hz (i.e., the power line frequency in Europe; for other nations the filter response
can be moved to 60 Hz). This filter achieves a clean signal in a frequency range defined “monitoring
band” that is suitable for ECG monitoring. The lower band limit of the filter is as low as possible in
order to allow the low-frequency components of the ECG signal to pass, but high enough to attenuate
the oscillations caused by the hand–electrode contact impedance variations. The heart rate is calculated
using the method of thresholding of the energy signal. In order to highlight the QRS complex, the ECG
signal is filtered again with a 15-Hz low-pass FIR filter and the resulting samples are squared, obtaining
a power signal. The power signal is then compared with a threshold that is proportional to the mean
value of the power signal itself over a time window, which represents the local energy of the signal.
When the threshold is exceeded, a QRS complex is detected and the time distance between near QRS
complexes allows us to calculate the heart rate. The microcontroller uses an UART port to send to
the Bluetooth module the filtered ECG samples to be forwarded to the gateway using the SPP profile.
The module can be configured in two working modes by pressing one of two buttons while powering
on the ECG device. In slave mode the module always waits for Bluetooth connection requests from the
gateway, whereas in the master mode the module itself sends connection requests when a previously
paired device is found. When a button is pressed the paired list is cleared and the device always waits
for a pairing request. Pairing procedure requires a PIN. The master mode allows the user to keep the
gateway always on and to establish an automatic connection just by powering on the ECG device.
Once connected, the firmware of the microcontroller provides autonomy and transparency to send
the ECG samples to the gateway. The microcontroller also drives the user interface, consisting of four
LEDs indicating the status of the device and a LCD that shows the heart rate value and the progress of
the acquisition.
For the overall power consumption let us consider a current consumption of about 100 mA,
drained from a supply voltage of 3.3 V. The 4-AA battery pack ensures more than 15 h of continuous
data streaming, which, considering its typical use in a telemedicine service (i.e., one measurement
per day), means approximately six months of autonomy.
5.2.4. Testing of a Prototype Single-Lead ECG Device
The first prototype was realized and its performance in terms of user-friendliness and ECG
quality was analyzed in an experimental trial with tens of testers, among them 12 elderly people
with an average age higher than 60. While simplicity is important to ensure usability by all patients,
ergonomics also has a relevant role in the quality of the ECG signal because it influences the stability of
the position of the patient during the acquisition. After receiving a few instructions, all the testers were
able to use the device without any help and reported as feedback that the position of the hands was
comfortable and easy to keep for some minutes. Figures 10 and 11 show the hands of a tester on the
prototype and the related ECG acquired. Another test campaign was done for comparing the quality
of the ECG obtained using the prototype with the ECG obtained using the Lifepak 15 configured in
the “monitor band” mode (i.e., 0.5 Hz–40 Hz). Figure 11 shows the result obtained, acquiring an ECG
simultaneously on the same tester using both the prototype (by placing the hands on the electrodes)
and the Lifepak 15 (by attaching the adhesive electrodes on the chest). The black trace on the graph
paper in Figure 11 is the printed output of the Lifepak, whereas the blue trace is the prototype data
using the new single-lead ECG device. The first two leads obtained at the same time with the two
different devices are very similar and overlap almost perfectly. The minimal worsening of the signal
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quality, mainly due to the limits imposed by the skin–electrode contact set-up, is acceptable considering
the significant improvements to the device usability.Electronics 2016, 5, 47 17 of 26 
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collaboration with CAEN spa, taking into account the typical constraints of biomedical signals 
monitoring like multi-lead ECG, blood pressure monitoring, and body temperature. With reference 
to the ASIC functional block in Figure 13, the main building blocks of the ASICs are described 
hereafter. A fully configurable multi-channel ECG block is present, with eight input differential 
channels (e.g., 16 input pins) for signal conditioning including amplification, filtering, and offset 
regulation for 3-5-12-leads ECG systems. There is also an adder generating the Central Terminal Point 
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Figure 11. Comparison of the ECG acquisition with the new single-lead ECG biomedical device
(blue trace) vs. a golden reference multi-lead ECG instrumentation (black trace). Electrodes placed on
the chest are needed only for the reference ECG. The proposed ECG device just requires placing the
hands, without any conductive gel, on top of the ECG device, where a couple of electrodes are placed.
Differently from [17], the newly developed single-lead ECG sensor can also be used as a stand-alone
personal care device in connection with a smartphone or tablet acting as a storage and display unit
(see Figure 12; the interface, in Italian in this specific example, can be regionalized according to the
device language settings). Through the BT connection the acquired signal is transmitted to an Android
OS-based terminal where a custom-developed app exploits the terminal processing and memory
hardware resources to filter the signal in the digital domain, displays the ECG trace on the LCD screen,
and allows us to build a repository of recorded ECG traces. Table 2 summarizes the main characteristics
of the single-lead ECG device.
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5.3. Multi-Channel Biomedical ASIC Sensor
5.3.1. General Architecture of the Biomedical ASIC
As discussed in Section 5.1, an ASIC has been designed and manufactured in AMS CMOS 2 Metal
Layers 2 Poly technology, to ensure multi-sensor integration in the same wearable and portable medical
device. The ASIC is assembled in a 14 ˆ 14 ˆ 1.4 mm3 TQFP (Thin Quad Flat Package) with 128 pins
and used at 3.3 V. The current drained from the power supply is 10 mA in typical operating mode
(i.e., 33 mW power consumption). Its operating temperature range is from 0 ˝C to 70 ˝C, which is fully
compliant with use at home. It ensures multiparametric biomedical signal acquisition. The ASIC has
been designed in the framework of the Health@Home European (EU) project in collaboration with
CAEN spa, taking into account the typical constraints of biomedical signals monitoring like multi-lead
ECG, blood pressure monitoring, and body temperature. With reference to the ASIC functional block
in Figure 13, the main building blocks of the ASICs are described hereafter. A fully configurable
multi-channel ECG block is present, with eight input differential channels (e.g., 16 input pins) for
signal conditioning including amplification, filtering, and offset regulation for 3-5-12-leads ECG
systems. There is also an adder generating the Central Terminal Point (CTP) for precordial leads,
a right leg (RL) driver, and a SHIELD driver to reduce the Common Mode 50 Hz noise. A pacemaker
detector section allows for pace pulses detection on a dedicated pin. All is in conformity with the
IEC 60601-2-51 2003-02 standard. There is also one analog channel designed for decoupling and
amplifying a blood pressure signal coming from an optional external pressure Sensor. Another input
analog channel is used to process a temperature signal provided by an external temperature sensor.
One programmable analog MUX allows for switching among the channels to be converted by the
ADC. A 16-bit SAR (Successive Approximation Register) ADC is used to convert the voltages from the
analog channels. The relevant Effective Number of Bits (ENOB) is 12. A serial peripheral interface
(SPI) [41] is used to configure the chip settings and for data readout. A dedicated battery channel is
present to monitor the battery status. On-chip diagnostic features, as in [43], are also integrated in the
biomedical ASIC.
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5.3.2. Analysis of Specific ASIC Channels
Hereafter we describe the architecture of the specific channels for the monitoring of ECG, blood
pressure, temperature, and device battery status.
Each single ECG channel is composed of an IA with high CMRR, a programmable gain amplifier
(PGA), a BUFFER, and an offset regulator block. The IA has a high CMRR (100 dB typical; 92 dB
minimum) in order to reduce environmental electric interferences, like the 50 Hz noise from the
industrial network, always present in both electrodes that are connected with human body, and the
ground. The power supply rejection ratio (PSRR) is 100 dB typical, 96 dB minimum. A first-order
high-pass filter, obtained through an external capacitor, removes the low-frequency baseline wandering
that is so common in ECG circuits (usually due to electrodes). An anti-aliasing filter is obtained with
an external RC network. A PGA is used to provide four gains, 18, 24, 36, and 48, for standard ECG
measurement. The IA has a gain of 15.6 set with an external resistor of 1.2 MΩ. Therefore, the total gain
can be configured up to roughly 700. The third stage is a buffer section with fast settling that sends
out the signal to the ADC. Each ECG channel has some switching MUXs placed in the input section,
and is configurable via SPI command. The architecture of the ECG channel implements a baseline,
therefore quickly rectifying any time variations in the signals due to artifacts that cause a temporary
saturation of the IA. Offset regulator and gains regulator procedures are also available for each channel.
If the ECG measurement is chosen, a cyclic procedure is activated, and the analog MUX connects this
section to the ADC. Within 100 µs (worst case), all the channels are processed. Each ECG processing
channel has also been characterized in terms of noise: the input referred noise measured in the range
0.1 Hz to 150 Hz is within 10 µVrms.
The Adder block is used to obtain the CTP signal reference to be used as inverting input for
each channel that receives a pre-cordial signal. A driven RL circuit (RL Driver block) helps to set the
common mode, and is safer than connecting the RL to voltage reference. The circuitry, able to drive in
active mode the shield of the ECG cables (SHIELD Driver block), helps reduce the Common Mode
50 Hz noise.
A pacemaker detector block is also integrated in the ASIC to provide band pass filtering on the
ECG signal, full wave rectification for detecting pacemaker pulses of either polarities, peak detection
on the filtered and rectified signals, and discrimination relative to a programmable threshold level.
Once a pacemaker pulse is detected, it provides on the dedicated output digital pin a pulse whose
duration is configurable via SPI.
The Blood Pressure section includes two channels. One is an analog channel that converts a DC
single-ended, ground-referred voltage to a differential voltage suitable to be converted by the on-chip
ADC; it amplifies this signal. Input signal ranges between 0.5 V (0 mmHg) and 1.7 V (300 mmHg).
The offset voltage for single-ended/differential conversion is provided by the internal references
generator block. Another analog channel amplifies the AC component of the input pressure signal
and translates the DC component around a reference voltage. Extraction of the AC component is
assured by two external capacitors and one external resistor. If the BP measurement is chosen, a cyclic
procedure is activated, and the MUX connects this section to the ADC.
The skin temperature measurement channel uses an NTC resistor as input sensor: the NTC
resistor has a nonlinear voltage–temperature characteristic so an additional circuit is used to improve
the linearity of the response in the range of the acquisition system from 32 ˝C to 42 ˝C, including
body temperature.
The ADC structure used in this design is a SAR architecture, made by three main blocks: a sample
and hold stage, a comparators stage, and a residue-multiplying DAC stage. ADC needs 16 clock cycles
(1 MHz) to produce a 16-bit output code. The ADC has an INL of ˘1 LSB and a DNL of 0.75 LSB (worst
case). The offset and error gain of the ADC are below 0.5% and 1.5% of the full scale range, respectively.
Finally, the battery channel is used to monitor the battery status. Integrated bandgap circuits are
used to internally generate reference levels from 1.1 V to 3.5 V.
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In the experimental trials in Section 6, the biomedical ASIC has been configured so that the
ECG is acquired involving three channels and the RL driver. The blood pressure channel and the
temperature monitoring are also used in some configurations. Table 3 summarizes the characteristics
of the biomedical ASIC.
Table 3. Characteristics of the biomedical ASIC.
Tech. Temp. VSupply ADC Channels ECG Channel
Gateway
Connection
CMOS 0.8 µm 0 to 70 ˝C 16 b 64 kSa/s 8 ECG,1 blood press 100 dB CMRR, 57 dB gain BT 2.0 SPP
TQFP128 pin 3 V to 5 V INL/DNL1/0.75 LSB 1 temp.,1 batt status 100 dB PSRR, 0.1 to 150 Hz
14 ˆ 14 ˆ 1.4 mm3 offset/gain error0.5/1.5% Pacer detect, 10 µVrms/150 Hz input noise
5.4. Motion Sensor for Fall and Posture Detection
As discussed in Section 5.1, a custom mobility sensor to study body movement has been developed
in the framework of the EU-Tuscany Region FESR project RIS (Research and Innovation in Healthcare
Systems) in collaboration with TD Nuove Tecnologie S.p.a. In more detail, the newly developed sensor
is able to extract the following parameters: fall detection, static detection (no movement is detected),
step detection, and stride estimation. The sensor has been designed to be small enough and have
a low enough weight that it can be worn, also for medium-term periods, without any impairment
of normal activities for the patient. The sensor in Figure 14 has been implemented on a small PCB,
equipped with System in Package (SiP) device containing a nine-axis MEMS Inertial Measurement
Units (IMU). The sensor contains a 3-axial gyroscope plus a three-axis accelerometer and a three-axis
digital compass. To fuse the information coming from the three sensors avoiding realignment or
calibration issues, proper digital signal processing algorithms are implemented in real time on a 32-bit
ARM Cortex-M processor. Two built-in algorithms run on the device: the first computing the step
detection, stride estimation, and energy consumption; the second determining falls or the absence
of movement. Communication with the gateway is based on a Bluetooth 4.0 LE chipset, integrated
into the device. The motion sensor can be supplied at 3.3 V draining a current of few mA in normal
operating mode. The onboard Li-Po rechargeable battery (3.7 V, 240 mAh) ensures about 80 h of
continuous data streaming. Its size is comparable to the size of a 50 euro cent coin.
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detect the stance phase (B2i) in a single step while walking. The fourth stage is detected in sample i 
when a swing phase ends and a stance phase starts. Estimating the Stride Length (SL) is necessary, at 
every detected step, in order to calculate the total forward movement of a person while walking. Here, 
SL depends on the person, his/her leg length and walking speed, and the nature of the movements 
during walking, etc. The algorithm proposed by Weinberg [20] assumes that SL is proportional to the 
bounce, or vertical movement, of the human hip. This hip bounce is estimated from the largest 
acceleration differences at each step. The algorithm implemented for SL estimation consists of the 
following steps. The first step computes the magnitude of accelerations ai. The second step estimates 
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determine a fall is based on the controls of the thresholds. A fall-like event is defined as an 
acceleration peak of magnitude greater than 3 g followed by a period of 2500 ms without further 
peaks exceeding the threshold. The accelerometer-sampling rate has been set at 50 Hz, a trade-off 
between resolution and power consumption. Threshold values around 3 g (ranging from 2.5 g to 3.5 
g) have been widely used in other fall detection systems [22]. The value 3 g is small enough to avoid 
false negatives, since real falls are likely to present an acceleration pattern containing a peak that 
exceeds such a value. Several sensor placements have been already tested, e.g., the waist, trunk, leg, 
hip, and foot. From our test, although data from all locations provided similar levels of accuracy, the 
hip was the best single location for recording data for activity detection. It provides better accuracy 
than the other investigated placements [23]. This location is optimal for the implementation of more 
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The algorithm implemented for step detection consists of four main stages. In the first stage,
the magnitude of the acceleration ai for each sa ple i, captured by the accelerometer, is computed.
In the second stage, the local acceleration variance is computed to remove gravity. The third stage
uses two thresholds: the first (T1) is applied to detect the swing phase, whereas the second (T2) is
applied to detect the stance phase (B2i) in a single step while walking. The fourth stage is detected
in sample i when a swing phase ends and a stance phase starts. Estimating the Stride Length (SL) is
necessary, at every detected step, in order to calculate the total forward movement of a person while
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walking. Here, SL depends on the person, his/her leg length and walking speed, and the nature of
the movements during walking, etc. The algorithm proposed by Weinberg [20] assumes that SL is
proportional to the bounce, or vertical movement, of the human hip. This hip bounce is estimated
from the largest acceleration differences at each step. The algorithm implemented for SL estimation
consists of the following steps. The first step computes the magnitude of accelerations ai. The second
step estimates the SL using the Weisberg expression in Equation (1) [19], where the maximum and
minimum operations are applied over the filtered accelerations in a window of size 2w+1 around
the sample i(p) corresponding to the p stance detection. In Equation (1) K is a constant that has to
be selected experimentally or calibrated. If the length SL, estimated by the method above, and the
frequency of the step is known, it is possible to derive the velocity of each step as the ratio of the
two sizes.







If the length SL, estimated by the method above, and the frequency of the step is known, it is
possible to derive the velocity of each step as the ratio of the two sizes. The algorithm implemented to
determine a fall is based on the controls of the thresholds. A fall-like event is defined as an acceleration
peak of magnitude greater than 3 g followed by a period of 2500 ms without further peaks exceeding
the threshold. The accelerometer-sampling rate has been set at 50 Hz, a trade-off between resolution
and power consumption. Threshold values around 3 g (ranging from 2.5 g to 3.5 g) have been
widely used in other fall detection systems [22]. The value 3 g is small enough to avoid false
negatives, since real falls are likely to present an acceleration pattern containing a peak that exceeds
such a value. Several sensor placements have been already tested, e.g., the waist, trunk, leg, hip,
and foot. From our test, although data from all locations provided similar levels of accuracy, the hip
was the best single location for recording data for activity detection. It provides better accuracy than
the other investigated placements [23]. This location is optimal for the implementation of more efficient
algorithms, as it allows a cleaner signal from the IMU. However, the exact position and orientation of
the platform on the hip are not important, because many algorithms only work with the magnitude of
sensor readings. Table 4 summarizes the characteristics of the motion sensor.
Table 4. Characteristics of the motion sensor.
Sampling Rare V Supply Sensor Digital Core Processing Output
50 sps 3.3 V 9D IMU (gyroscope,accelerometer, digital compass) STM32
Fall event detection
Posture detection BLE 4.0
6. Experimental Trials
6.1. Experimental Trial Projects and Motivations
The proposed telemedicine platform, comprising remote monitoring kits (i.e., biomedical sensors
and gateways), service center applications, and Electronic Health Records, has been developed and
improved in the framework of different funded projects (ongoing or recently closed).
Health@Home EU Ambient Assisted Living project: remote monitoring of CHF patients recently
dismissed from hospital through self-measurement of the main vital signs.
Domino project, funded by Arezzo’s local health authority: remote monitoring of chronic patients
(mainly cardiac) with periodic in-house visits performed by nurses and circulation of clinical data
among all personnel involved in the patients’ care (e.g., family doctors, specialists, etc.).
RIS (Research and Innovation in Healthcare Systems) EU-Tuscany Region FESR project:
personalized and integrated remote monitoring of chronic patients, connecting in-hospital care
and out-of-hospital follow-up based on the “1:1” scenario (self-measurements) or “1:N” scenario
(measurements made by professional caregivers).
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RACE (Research and Accuracy in Cardiology based on Evidence of clinical data) EU-Tuscany
Region FESR project: long-term trial with health economic analysis in order to evaluate the impact of
the telemedicine model on the economic burden of the PHS.
All these projects included a trial phase in the real-world telemedicine scenario with the
involvement of patients and medical personnel. An exhaustive in-field demonstration phase is
crucial to assess and improve the effectiveness of telemedicine platforms. The primary outcomes of
our validations were, from a technical point of view, the usability of the system and its affordability,
whereas from the medical point of view they were the quality of the clinical data and the ability to
improve patient care.
6.2. Health@Home Experimental Trial Results
In the trial prepared for the Health@Home project, the platform was used according to the “1:1”
scenario. The validation of the telemedicine platform was implemented involving 30 patients (average
age of 62 years) affected by CHF coming from three different hospitals (Hospitales Universitarios
Virgen del Rocio in Spain, Zdravstveni Dom Koper in Slovenia, and Fondazione Toscana Gabriele
Monasterio in Italy), under the supervision of two doctors specializing in cardiology from each hospital.
The minimum monitoring period was three months. Inclusion criteria included diagnosis of heart
failure, New York Heart Association (NYHA) classes III and IV, at least one hospitalization for acute
heart failure in the previous six months, and agreement to take part in the study. Acute coronary
syndrome within three months before the enrollment was the only exclusion criterion. Patients were
enrolled in the study at time of discharge from the hospital where they were admitted for acute
heart failure or during a routine ambulatory visit. At enrollment time they received a monitoring
kit with digital scale, blood pressure monitor, oximeter, ECG device, telemedicine gateway, and brief
training on how to use the system. Both a technical and a medical contact were available for patients
during the trial.
In order to validate the platform, specialist doctors were asked to check the information that
arrived to HIS, evaluating the quality and coherence of the data collected and the relevance of the
alarms automatically generated by the platform. Moreover, a specific questionnaire was developed to
gather feedback from patients, caregivers, family, and specialist doctors about the end-user usability.
The robustness of data storage and data transmission was also evaluated.
The results show a very limited number of activity misses (<3%), mostly in the first days of
monitoring, also confirming the property of such a telemedicine system to improve the therapy
compliance. Additionally, the number of false positive alarms is less than 5%. No connectivity, storage,
and transmission problems, including data loss, occurred. All end-users reported valid impressions of
the platform and a good satisfaction level in the final questionnaire. Table 5 and Figure 15 show the
scores reached in each macro-parameter for medical staff and patients, respectively. Medical personnel
reported that the use of this platform does not impinge on their regular activity, while it represents
a valid means of controlling at a distance the progress of their patients thanks to the high quality of
acquired signals and alarm detection capability. All specialist doctors are definitively in favor of the
adoption of the platform. In addition, 89% of patients report a very high satisfaction level, highlighting
the friendliness of the solution and the ease of following the daily therapy.
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Table 5. Aggregated feedback from specialist doctors.
Macro-Parameter Score
Simply decision and increase effectiveness of diagnosis and treatment of patient
based on better evidence 9,125/10
In general terms, easy to use with clear and understandable interactions 9,5/10
Flexibility of the system and compatibility with other systems already in use 9,75/10
Quality of the provided signal 9,1/10
Sensibility of the alarm detection function 9,15/10
In favor of the adoption of the H@H system 9,2/10
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6.3. Domino Experimental Trial Results
The trial carried out in the Domino project exploited the potential of the presented platform
for the provisioning of a telemedicine service according to the “1:N” scenario. In particular, under
the supervision of the Local Health Authority of the city of Arezzo in Italy (ASL8), a group of
50 consenting chronic patients mainly affected by cardio-respiratory diseases (e.g., CHF, COPD) and
already following the Chronic Care Model procedures was monitored for a period of six months.
According to the “1:N” scenario, the proposed telemedicine equipment was used by two nurses
allocated by the ASL8 to this trial during the domiciliary visits. In this study, a telemedicine kit with
a gateway and a set of biomedical sensors (i.e., 12-lead ECG device, oximeter digital scale, blood
pressure monitor, glucometer, and spirometer) was provided to each nurse in order to collect vital
signs during the domiciliary visits scheduled according to the personalized healthcare plan of each
patient. This ICT-assisted method allowed an almost real-time distribution of the acquired vital signs
to all people interested in the patient’s care thanks to the automatic transmission of data directly after
the acquisition from the gateway to the online platform.
In order to evaluate the platform in term of usability, impact with respect to the traditional method,
and capacity to improve the management of the chronic patients, medical personnel involved in the
pilot were interviewed at the end of the period. Additionally, the robustness of data storage and data
transmission was evaluated.
From a technical point of view, no data loss occurred during the trial. In some cases real-time
transmission of the collected data was not possible due to missing availability of mobile broadband
connectivity. The main benefits of the “1: N” solution, highlighted by the medical staff, are:
- Synchronization of the vital signs of the patients as soon as they are acquired in the e-Health
center, through an automatic procedure that minimizes the possibility of errors due to manual
insertion of values.
- Clinical information sharing among the family doctor, the specialists, and the rest of the caregivers,
without any time or distance barriers.
- Reduction of the duration of the domiciliary visits, and a better scheduling of the work flows.
Table 6 summarizes the interviews with the nurses who used the telemedicine kit.
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Table 6. Nurses interviewed in Domino project.
“The patient selection process and the measurement acquisition process are quickly and easy to use”
“The medical devices provided with the gateway cover acquisition of all the requested vital signs”
“The telemedicine kit, composed of a gateway and medical devices, represents an important improvement and
optimization of the domiciliary visit with respect to the traditional model”
6.4. RIS Experimental Trial Results
In the framework of the RIS project, the complete telemedicine platform described in previous
sections was extensively tested. The rationale was to test the ability of the platform to provide effective
telemedicine services involving in an integrated and coordinated fashion the hospitals, the territorial
services (i.e., family doctors, local Health Authorities, etc.) the clinical specialists, and in general all
the caregivers and stakeholder of the healthcare system. For these reasons, all paradigms described
in Section 3 were used in the pilot: self-measurements performed by the patients, domiciliary visits
assigned to nurses and health corners in public places (e.g., pharmacies, medical centers, residences for
elderly people, etc.). Moreover, the platform enhanced the role of the service center as a central point
of the architecture for the circulation, management, and sharing of clinical information. Operators
received specific training in how to manage the data coming from the telemedicine systems and how
to handle alarms. A group of 10 chronic patients, with CHF as the main complaint but also affected by
some comorbidities such as diabetes, was monitored for at least one month according to a structured
and personalized healthcare program that included self-measurements and periodic (i.e., weekly)
in-house visits.
At the end of the trial, the overall platform was evaluated through questionnaires and direct
interviews. The metrics established for the evaluation of the system belong to two main categories:
objective and subjective. The first are related to items that are unequivocally measurable; the latter
depend on the personal experience during the demonstration and the individual’s feeling about the
system. The quality of the vital signs, self-measured by the patients or collected by the nurses allocated
to domiciliary visits, was confirmed by specialist doctors, who also assessed the capability of the
platform to improve the treatment of chronic patients in terms of therapy compliance, clinical outcomes,
alarm situation handling, and better allocation of medical resources. The platform, as already assessed
in the previous pilots, confirmed its robustness and flexibility, avoiding data loss and ensuring secure
circulation of clinical information.
7. Conclusions
This paper has presented the implementation and experimental verification of a remote
monitoring system including the whole value chain from the top (health care model) down to
the technical implementations of sensors, data acquisition, processing, a communication platform
(gateway), and integration with a service center and HIS. The proposed system is scalable in different
telemedicine scenarios involving different roles for all the actors in a health system (patients, their
family, nurses, doctors, institutions, local health corners, call center operators): to this end the “1:1,”
“1:N,” and “point of care” scenarios are presented and discussed. A mixture of commercially available
sensors and new custom ones are presented and used. The new custom-designed sensors range
from a single-lead ECG for easy self-measurements at home, to a multi-channel biomedical ASIC
for acquisition of multi-channel bio signals (e.g., ECG, EEG, EMG), to a new motion sensor for
patient posture estimation and fall detection. Specific focus has been placed on aspects such as
the user interface and easy use of the device for non-professional users. From a communication
point of view, BT and BLE wireless PAN links are used between sensors and gateway, whereas
wireless LAN or wired technologies are used between the gateway and the remote server. All data
can be transferred though several protocols, including HL7 CDA. Experimental trials in real-world
telemedicine applications assess the proposed system in terms of easy usability for patients, family
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members, specialist doctors, and caregivers; in terms of scalability in different scenarios; and in terms
of suitability for the implementation of needed care plans.
Since the number and type of patients involved in the reported experimental trials (see Sections 6.2–6.4)
are still not enough to claim a complete survey and reliable statistics, there is ongoing experimental
activity. The aim of the ongoing activity is also to validate the efficacy, in terms of economic advantages
and impact on the conventional organization of people and infrastructures, of the telemedicine
scenarios for the PHS. The psychological acceptance of the telemedicine model from a large part of the
population should also be validated. To this end, the telemedicine system can also be supported by a
remote videophone service, exploiting compression technologies we already developed in [44–46]—thus
the patient can also “see” the doctor. Moreover, ongoing activity is focused on implementing a reliable,
automatic check of the quality of the acquired biomedical measurements. Currently, an automatic check
is done by the system but with a coarse grain (e.g., if acquired data or their difference with previous
acquisitions are above or under some specific thresholds), whereas a fine-grain analysis of the quality
of the acquired signal is left to the subjective analysis of the professional caregiver. Finally, in the
current implementation the alarms generated by the gateway must be first validated by the caregiver
before an emergency plan is activated and the patient is re-hospitalized. This increases the latency
of reaction to an alarm, which can be critical particularly if the patient’s home is far from a hospital
(e.g., mountainous zones and/or regions with low population density). In the future, when reliable
automatic diagnosis of the quality of the measurements is reached and the system has been tested on
a large population of patients with reliable statistics, automatic activation of the emergency plan can
be instituted.
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